Evidence map›Paper›PMID 42894709›Full record

ReviewMedical hypothesis, discovery & innovation ophthalmology journal2026

Nd:YAG capsulotomy: an update.

Teslime Aydemir Sali, Eyyup Karahan

Abstract readReview
In one paragraph

Review in Medical hypothesis, discovery & innovation ophthalmology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Teslime Aydemir SaliBalikesir University Faculty of Medicine, Department of Ophthalmology.
Eyyup KarahanBalikesir University Faculty of Medicine, Department of Ophthalmology.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Posterior capsule opacification (PCO) remains one of the most common late complications following cataract surgery and may lead to decreased visual acuity, glare, contrast sensitivity loss, and impaired visual quality. Nd:YAG laser posterior capsulotomy is currently accepted as the gold standard treatment for symptomatic PCO because of its non-invasive nature and rapid visual rehabilitation. However, despite its widespread use and generally favorable safety profile, concerns remain about procedural variability, postoperative management, and complications such as intraocular pressure elevation, cystoid macular edema, retinal complications, and intraocular lens damage. This updated narrative review aimed to summarize and expand the current evidence on the mechanisms, indications, techniques, outcomes, and complications of Nd:YAG laser posterior capsulotomy. Methods: A narrative literature review was conducted using PubMed/MEDLINE, Scopus, and Web of Science databases, supplemented by Google Scholar screening. The review primarily focused on studies published between 2010 and 2026, although landmark earlier studies were also included when relevant. Primarily English-language publications were included. The search strategy included combinations of the keywords "Nd:YAG capsulotomy", "posterior capsule opacification", "photodisruption", "intraocular pressure", "retinal detachment", "cystoid macular edema", "capsulotomy size", and "intraocular lens". Original articles, clinical studies, systematic reviews, meta-analyses, guideline-based publications, and selected case reports were included. Duplicate publications, conference abstracts without accessible full text, and studies with insufficient methodological or clinical information were excluded. Results: Current evidence demonstrates that Nd:YAG laser capsulotomy provides effective visual rehabilitation in symptomatic PCO and remains a generally safe procedure. Studies evaluating procedural techniques indicate that both cruciate and circular capsulotomy patterns produce comparable visual outcomes, though differences may exist in energy usage, floaters, light scattering, and macular effects. Significant variability persists in clinical practice regarding timing, postoperative medication use, and follow-up protocols. Although most complications are uncommon, clinically important adverse events including retinal detachment, cystoid macular edema, intraocular pressure elevation, inflammation, and intraocular lens pitting have been reported. The risk of certain complications appears to be influenced by patient characteristics, laser energy levels, capsulotomy size, ocular comorbidities, and the interval between cataract surgery and capsulotomy. Conclusions: Nd:YAG laser posterior capsulotomy remains an effective and reliable treatment for symptomatic PCO; however, important heterogeneity persists regarding procedural approaches and postoperative management. Current evidence suggests that individualized treatment planning, careful patient selection, and conservative energy settings may help minimize complications. Future prospective and standardized studies focusing on visual quality outcomes, patient-reported measures, optimal timing, and complication risk stratification are needed to improve standardization and clinical decision-making in Nd:YAG laser capsulotomy practice.

Indexed as

capsule opacificationscystoid macular edemaintraocular lensintraocular lens implantationintraocular pressuresirvine-gass syndromelaser posterior capsulotomylens posterior capsuleNd-YAG laserretinal detachments

Identifiers

PMID42894709
PMCPMC13676808

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.